Eshmuno® Fit Custom Affinity Resin Development Services
Streamline your downstream processing with Eshmuno® Fit custom affinity resin development services. Our approach utilizes tailored caustic-stable Nanofitin® ligands designed specifically for your target molecule and conjugates them to our well-established Eshmuno® base beads. This enables the creation of custom and optimized affinity resins to address your specific purification challenges.
Benefits:
- High yield, even for difficult-to-purify molecules
- High purity levels can be achieved in just one step, streamlining the purification process
- Improves and simplifies the overall purification workflow by reducing the number of downstream processing steps
- Cost savings from optimized and simplified downstream processes, high efficiency, and increased recovery of valuable therapeutics
- Easy to scale, ensuring consistent performance through scale-up and flexible manufacturing
Why choose Eshmuno® Fit custom affinity resin development services?
- Diversity: Our technology relies on a library of over 1e14 Nanofitin® variants, enabling custom generation of ligands for affinity separation of various target molecules such as vaccines, viral vectors, and novel mAbs.
- Tailored caustic stability: Allows for reusability and the reduction of consumables costs.
- Versatility: Randomization of binding sites combined with a ribosomal display screening platform allows for the customization of ligands to specific interactions and tailored process conditions.
- Templated manufacturing: Manufactured under controlled conditions. Established quality system, certified ISO 9001, and Rx-360 audited site.
- Project execution: Ensuring the implementation of the custom affinity resin from start to finish through our dedicated team of technical experts and project managers.
Eshmuno® FIT Framework


Small-Scale Prototypes
- Up to 3 pre-packed prototypes of selected ligands coupled with Eshmuno® matrix
- Physical characterization testing
- Functional testing, including static binding capacity, dynamic binding capacity, and cleaning-in-place

Research-scale Prototypes
- 6 statistical batches, including bicinchoninic acid (BCA) protein assay and dynamic binding capacity
- Research scale production (ISO9001)
- QC testing, including bicinchoninic acid (BCA) protein assay, dynamic binding capacity, etc.

Production Transfer & Qualification
- Scale-up of Nanofitin® ligand and resin production
- Definition of extended specifications
- Validation of analytical methods
- Process validation through qualification batches
- Quality and regulatory compliance for GMP applications
- Regulatory support files
Related Resources
- Eshmuno® Fit Services - Application Note
Custom Affinity Resin Development Services to Streamline Downstream Processing of Difficult to Purify Molecules
- Eshmuno® Fit Services - FAQ
This document lists all the frequently asked questions about Eshmuno® Fit Custom Affinity Resin Development Services.
- Vaccine Manufacturing: Collaboration Helps to Overcome Vaccine Process Challenges
This white paper showcases collaborative technology-development efforts carried out by the DiViNe consortium to advance the use of an innovative affinity chromatography platform during vaccine manufacturing.
- Enabling Vaccine Production - Solving Challenges Together
This eBook presents a series of vaccine case studies highlighting our recent collaborations with organizations and thought leaders
To continue reading please sign in or create an account.
Don't Have An Account?